Zhejiang Xinguang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 34.3% in First Three Quarters of 2023

Zhejiang Xinguang Pharmaceutical Co.,Ltd. (浙江新光药业股份有限公司) (300519.SZ) reported a net profit of 58.7 million yuan in the first three quarters of 2023, down 34.3% year-on-year.

Meanwhile, the company posted 216.1 million yuan in revenue, down 17.7% year-on-year.

At the end of the reporting period, it had 919.3 million yuan in total assets and 81.2 million yuan in total liabilities, with a liability-to-asset ratio of 8.8%.